Literature DB >> 3304456

Structure-function relationship of human von Willebrand factor.

J P Girma, D Meyer, C L Verweij, H Pannekoek, J J Sixma.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3304456

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  25 in total

1.  Fetuin-A, a hepatocyte-specific protein that binds Plasmodium berghei thrombospondin-related adhesive protein: a potential role in infectivity.

Authors:  Deepa Jethwaney; Timothy Lepore; Saria Hassan; Kerrianne Mello; Radha Rangarajan; Willi Jahnen-Dechent; Dyann Wirth; Ali A Sultan
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Characterization of a genetically engineered inactivation-resistant coagulation factor VIIIa.

Authors:  S W Pipe; R J Kaufman
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

3.  A monoclonal antibody to von Willebrand factor (vWF) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWF polypeptide.

Authors:  W F Bahou; D Ginsburg; R Sikkink; R Litwiller; D N Fass
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

4.  Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA.

Authors:  D Ginsburg; B A Konkle; J C Gill; R R Montgomery; P L Bockenstedt; T A Johnson; A Y Yang
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

5.  150-kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen.

Authors:  J H Rand; N D Patel; E Schwartz; S L Zhou; B J Potter
Journal:  J Clin Invest       Date:  1991-07       Impact factor: 14.808

6.  A monoclonal antibody recognizes a von Willebrand factor domain within the amino-terminal portion of the subunit that modulates the function of the glycoprotein IB- and IIB/IIIA-binding domains.

Authors:  I Tornai; J Arnout; H Deckmyn; K Peerlinck; J Vermylen
Journal:  J Clin Invest       Date:  1993-01       Impact factor: 14.808

7.  Proteomic characterization of plasma-derived clotting factor VIII-von Willebrand factor concentrates.

Authors:  James G Clifton; Feilei Huang; Spomenka Kovac; Xinli Yang; Douglas C Hixson; Djuro Josic
Journal:  Electrophoresis       Date:  2009-10       Impact factor: 3.535

8.  Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.

Authors:  S Layet; J P Girma; B Obert; E Peynaud-Debayle; N Bihoreau; D Meyer
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

9.  Endothelial-cell-specific regulation of von Willebrand factor gene expression.

Authors:  N Jahroudi; D C Lynch
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

10.  O-linked carbohydrate of recombinant von Willebrand factor influences ristocetin-induced binding to platelet glycoprotein 1b.

Authors:  J A Carew; S M Quinn; J H Stoddart; D C Lynch
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.